Genmab A/S has appointed Rolf Hoffmann, a veteran pharmaceutical executive, as an observer on its board of directors in anticipation that he will stand for election to the board in 2017. As an observer, Mr Hoffmann will participate in board meetings but he will not have a vote.
Mr Hoffmann was most recently senior vice president and head of US commercial operations at Amgen Inc. Prior to this, he held management positions at Eli Lilly and Company for more than 17 years in South Africa, Latin America and Germany. He took retirement from Amgen at the end of July and among his current roles is as adjunct professor for strategy and entrepreneurship at the University of North Carolina Business School.
Genmab announced the assignment on 3 August 2016.
Copyright 2016 Evernow Publishing Ltd